For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

Geopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...

Market expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...

Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

What we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Over the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...

Shares of Syngene International dropped 5.7%, Piramal Pharma fell 4.2%, Lauras Labs and Neuland Laboratories declined 3% and Divi's Laborat...

Despite a broad market sell-off since September, which has seen stocks fall by 15-50%, a select group of stocks with market caps above ₹5,0...

Goldman Sachs' ratings triggered price movements, with Syngene and Neuland rising but Laurus falling. Syngene is set to benefit from China+...

Sustained capital outflow amid weak Asian cues also dented sentiment.

The NSE Nifty index was trading 56.65 points up at 9,101.85 in the afternoon trade on Tuesday following firm global cues.

The Chinese currency has appreciated about 5 per cent in the last five years compared with the Indian currency, which has depreciated about...

Vishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...